Dose Dependent Effect of Sulfamethoxazole on Inhibiting KATP Channel of Mouse Pancreatic β Cell

KATP Channel Mutations and Neonatal Diabetes

(2017) Kenju Shimomura et al.   INTERNAL MEDICINE

Trimethoprim-sulfonamide use during the first trimester of pregnancy and the risk of congenital anomalies

(2015) Craig Hansen et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Serum Peak Sulfamethoxazole Concentrations Demonstrate Difficulty in Achieving a Target Range: A Retrospective Cohort Study

(2014) Bao D. Dao et al.   CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL

Safety of Cotrimoxazole in Pregnancy

(2014) Nathan Ford et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Hypoglycemia After Antimicrobial Drug Prescription for Older Patients Using Sulfonylureas

(2014) Trisha M. Parekh et al.   JAMA Internal Medicine

Molecular Mechanism of Sulphonylurea Block of KATP Channels Carrying Mutations That Impair ATP Inhibition and Cause Neonatal Diabetes

(2013) P. Proks et al.   DIABETES

Pharmacogenomic analysis of ATP-sensitive potassium channels coexpressing the common type 2 diabetes risk variants E23K and S1369A

(2011) Veronica Y. Lang et al.   Pharmacogenetics and Genomics

Symptomatic Hypoglycemia Associated with Trimethoprim/Sulfamethoxazole and Repaglinide in a Diabetic Patient

(2010) Matthieu Roustit et al.   ANNALS OF PHARMACOTHERAPY

Carbutamide — The first oral antidiabetic

(2009) H. Kleinsorge   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Severe Hypoglycemia Associated with Use of Trimethoprim/Sulfamethoxazole in a Patient with Chronic Renal Insufficiency

(2008) Jamie M Rosini et al.   ANNALS OF PHARMACOTHERAPY

Mechanism of disopyramide-induced hypoglycaemia in a patient with Type 2 diabetes

(2008) M. Negishi et al.   DIABETIC MEDICINE